Galderma Laboratories has secured a further six month contract with X/procure®, Primedia Unlimited’s subsidiary specialising in electronic pharmaceutical procurement and direct-to-pharmacy advertising.

The next six months see a second aggressive Intervention campaign for Galderma’s Benzac AC-5 Acne Gel, a topical bactericidal and anti-inflammatory benzoyl peroxide preparation. X/procure®‘s Intervention Adverts are a repetitive reminder to the ordering pharmacist, giving the product an upper hand against competing acne treatments in the same category. X/procure®‘s Announcement Screens will also be utilised to build Benzac’s brand awareness.

Benzac Product Manager Peter McGill comments, “Benzac is the market leader in the OTC Acne category. We chose to renew with X/procure® as we believe Benzac’s presence on the system improves brand awareness and effectively communicates its Unique Selling Points to the purchase decision maker. Advertising on the X/procure® interface enabled us to grow our market share on orders placed via X/Procure® by 3.9% to an overall market share of 52.3% within the category between January 2009 and October 2009.”

The X/procure® software is currently installed in over 1200 pharmacies nationwide. The Galderma campaign will feature across the X/procure base® until July 2010.

For more information about X/procure®, visit www.xprocure.com

Issued on behalf of: X/procure®
JD Henderson
Acting Managing Director
T: +27 11 562 6500

Prepared by: Owlhurst Communications
Charlene Dennis
Publicist
T: +27 11 234 6520